ArticleDiabetes care2016
Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
Subodh Verma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
111 papers cite itlatest 60 shown
this paperpooled ittrialcites it